Johnson & Johnson - 52 Year Stock Price History | JNJ

Historical daily share price chart and data for Johnson & Johnson since 1970 adjusted for splits. The latest closing stock price for Johnson & Johnson as of August 18, 2022 is 166.77.
  • The all-time high Johnson & Johnson stock closing price was 184.85 on April 25, 2022.
  • The Johnson & Johnson 52-week high stock price is 186.69, which is 11.9% above the current share price.
  • The Johnson & Johnson 52-week low stock price is 155.72, which is 6.6% below the current share price.
  • The average Johnson & Johnson stock price for the last 52 weeks is 170.71.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2022 173.0082 169.3675 184.8460 157.1504 166.7700 -1.26%
2021 161.2917 150.7056 174.9844 148.3224 168.9035 11.45%
2020 138.4696 136.8110 151.5531 104.8446 151.5531 10.85%
2019 125.2393 117.3274 137.2515 115.4630 136.7173 15.35%
2018 120.4970 124.4998 135.7783 108.2429 118.5213 -5.14%
2017 114.5731 100.9778 127.7725 97.4213 124.9379 24.40%
2016 97.6992 85.1861 107.8391 81.1760 100.4287 15.32%
2015 83.3012 86.0471 89.2301 76.3613 87.0852 1.16%
2014 81.8994 72.9209 89.3401 69.3882 86.0882 17.34%
2013 67.7186 55.0785 76.6057 55.0007 73.3694 34.62%
2012 51.1039 49.4040 55.8945 47.1909 54.5031 10.83%
2011 46.7805 45.4542 50.0208 42.0983 49.1790 9.89%
2010 44.1501 45.2031 46.5009 40.5231 44.7523 -0.58%
2009 39.7462 41.0073 45.3988 31.7729 45.0144 11.28%
2008 43.2428 43.3407 48.4482 37.4103 40.4529 -7.77%
2007 41.5218 42.5757 44.9781 38.6969 43.8602 3.61%
2006 39.4198 38.6055 44.0561 35.5799 42.3321 12.44%
2005 40.1084 38.6357 42.8106 37.6095 37.6471 -3.36%
2004 34.0134 31.1226 39.1639 29.9524 38.9551 25.17%
2003 31.4037 32.7538 34.8698 29.2229 31.1226 -2.11%
2002 33.8812 34.2805 38.3660 24.5987 31.7948 -7.88%
2001 30.1424 29.3905 35.6062 24.0693 34.5141 13.97%
2000 25.6006 26.2527 30.2837 19.5771 30.2837 14.04%
1999 26.6351 23.2775 30.2138 21.6758 26.5545 12.46%
1998 20.9933 18.0784 25.0538 17.7839 23.6125 28.99%
1997 16.4647 13.6299 18.6008 13.6299 18.3063 34.31%
1996 13.1982 11.3714 14.7258 11.3714 13.6299 18.11%
1995 9.2152 7.2183 12.3499 7.1189 11.5401 59.14%
1994 6.0547 5.8492 7.3679 4.7801 7.2514 24.99%
1993 5.3625 6.2442 6.2442 4.5779 5.8014 -8.93%
1992 6.1699 6.9535 7.2094 5.3900 6.3704 -10.19%
1991 5.5093 4.2626 7.1549 3.9958 7.0929 62.34%
1990 3.7897 3.5709 4.4236 3.1010 4.3691 23.39%
1989 2.9543 2.4389 3.5410 2.4389 3.5410 42.63%
1988 2.3326 2.2229 2.5543 2.0021 2.4826 16.52%
1987 2.4349 1.8894 2.9610 1.8255 2.1307 15.79%
1986 1.7691 1.4238 2.0610 1.3104 1.8401 27.42%
1985 1.2063 0.9503 1.5025 0.9370 1.4441 49.85%
1984 0.8982 1.0536 1.0922 0.7403 0.9637 -8.53%
1983 1.1625 1.2462 1.2878 1.0116 1.0536 -15.66%
1982 1.0168 0.9000 1.2839 0.8034 1.2492 36.94%
1981 0.8287 0.7975 0.9334 0.6959 0.9122 14.54%
1980 0.6253 0.5960 0.7984 0.5200 0.7964 29.41%
1979 0.5522 0.5608 0.6212 0.4993 0.6154 10.48%
1978 0.5737 0.5541 0.6665 0.4897 0.5570 -1.76%
1977 0.5147 0.5655 0.5670 0.4558 0.5670 0.43%
1976 0.6212 0.6445 0.6883 0.5212 0.5646 -12.04%
1975 0.6334 0.5881 0.7048 0.5225 0.6419 12.02%
1974 0.6952 0.7856 0.8382 0.5309 0.5730 -27.71%
1973 0.8338 0.8993 0.9133 0.7346 0.7926 -13.22%
1972 0.8240 0.6815 0.9239 0.6615 0.9133 32.98%
1971 0.5922 0.3971 0.6894 0.3971 0.6868 73.74%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $440.598B $93.775B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $301.034B 38.17
Pfizer (PFE) United States $276.521B 8.10
AbbVie (ABBV) United States $250.080B 10.63
Novo Nordisk (NVO) Denmark $237.182B 31.29
Merck (MRK) United States $230.630B 12.04
Novartis AG (NVS) Switzerland $188.558B 13.90